Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
3 in 5 people Have Side Job to Help Make Ends Meet - Herbalife Asia Pacific Survey 2023-05-09 12:22
IND Application for Phase Ⅲ Registration Study of KN026 in Combination with Chemotherapy for the First-line Treatment of Breast Cancer Was Approved by CDE 2023-05-09 10:00
Singlera Genomics Receives FDA Breakthrough Device Designation for PDACatch, a Liquid Biopsy Assay for Pancreatic Cancer Detection in High-Risk Individuals 2023-05-08 22:00
CIVCO Radiotherapy and Qfix Showcase as One Company at ESTRO 2023 2023-05-08 22:00
EmeTerm Anti Fatigue & Car Sickness Wristband Wins the IF and IDA Design Awards 2023-05-08 21:00
PharmAbcine to participate in "BIO International Convention 2023" 2023-05-08 20:00
Chance Pharmaceuticals and Acorda Therapeutics Announce Agreement to Provide INBRIJA® in Greater China 2023-05-08 19:30
Hummingbird Bioscience to Present Preclinical Proof of Concept for Potentially First-In-Class Antibody Targeting Autoimmune Diseases 2023-05-08 18:30
Ascletis Announces China NMPA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection 2023-05-08 16:50
MEDICAL IP Is Creating Medical Digital Twins in Virtual Spaces, Powered by NVIDIA Omniverse 2023-05-08 16:00
Transcenta to Present Two Clinical Trial Progress at ASCO 2023 2023-05-08 14:55
Neuro3 Therapeutics Acquires Exclusive Worldwide Rights to Develop and Commercialize Clinical Stage KCNQ2 Activators from Lundbeck 2023-05-08 14:00
Bolivian and Taiwanese Experts Discuss the Latest Med-Tech Developments to Position Bolivia as a Leading hub in Robotic Neurosurgery 2023-05-08 13:29
EirGenix's Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1 Clinical Trial Objectives 2023-05-08 10:00
Innovent Announces First Participant Dosed in Phase 3 Study (RESTORE) of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Eye Disease 2023-05-08 08:00
Duoning Biotech Celebrates Ground Breaking for Its Global Headquarters 2023-05-08 08:00
Innovent Updates the Results from the ORIENT-31 Study of Sintilimab Plus Chemotherapy With or Without Bevacizumab in Patients with EGFR-TKI failed EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer in the Lancet Respiratory Medicine 2023-05-08 08:00
World Lupus Federation Urges Global Community to Raise Lupus Awareness on May 10 for World Lupus Day 2023 2023-05-08 08:00
BLISS BIOPHARMACEUTICAL ENTERS INTO A CLINICAL TRIAL COLLABORATION AGREEMENT WITH AN OPTION OF STRATEGIC COLLABORATION WITH EISAI FOR BB-1701 2023-05-08 07:00
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study 2023-05-08 05:00
1 201 202 203 204 205 970